The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    The (sick) kids aren’t alright: Observations from a teacher with Long COVID

    Flynn Lovelace

    We must help students by addressing Long COVID and advocating for clean air in schools. Read more…

Recent articles

  • How to interpret clinical trial results for Long COVID
    Science
    Simon Spichak

    How to interpret clinical trial results for Long COVID

  • Research updates, July 21
    Science
    Miles W. Griffis

    Research updates, July 21

  • National COVID-19 trends, July 21
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, July 21

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Abandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersAbandoned by our governments, people with severe ME and Long COVID are supported by severely ill peersWhitney Fox
What can professional athletes teach us about Long COVID and rest?What can professional athletes teach us about Long COVID and rest?Melanie Marich
How to interpret clinical trial results for Long COVIDHow to interpret clinical trial results for Long COVIDSimon Spichak
National COVID-19 trends, July 21National COVID-19 trends, July 21Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • close up photo of handful of medicines
    October 22, 2024

    Research updates, October 22

  • October 18, 2024

    Clinical trials explore how Low-Dose Naltrexone could help people with Long COVID

  • Three researchers stand in a health clinic's waiting area, in between armchairs and a piano. Amy Proal on the left has blonde hair and wears a floral shirt; David Putrino in the middle wears a blue shirt and slacks; Joseph Herrera on the right wears a navy suit. All three wear KN95 masks.
    October 15, 2024

    New Long COVID and complex disease center at Mount Sinai set to be a leader in research, clinical care

  • closeup of little atoms under a microscope
    October 15, 2024

    Research updates, October 15

  • photo of pen on top of notebook
    October 8, 2024

    Research updates, October 8

  • October 1, 2024

    “A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meeting

Previous Page
1 … 23 24 25 26 27 … 37
Next Page

Covid-19

  • April 23, 2024

    National Covid-19 trends, April 23

  • April 16, 2024

    National Covid-19 trends, April 16

  • April 9, 2024

    National Covid-19 trends, April 9

  • April 2, 2024

    “Refusing imposed endings”: An interview with Alec Finlay on Scotland’s Covid Memorial

  • April 2, 2024

    National Covid-19 trends, April 2

  • March 26, 2024

    National Covid-19 trends, March 26

Previous Page
1 … 23 24 25 26 27 … 30
Next Page

Health

Commentary

  • A graphic featuring a photo of the Long COVID Treatment Trial testing kit: a package, colored teal on the inside, that includes a Garmin device, smart scale, and other supplies for the trial, along with instructions. The kit is shown three times, with a background that is light orange with white spots
    October 30, 2025

    We need more at-home clinical trials for Long COVID. Here’s how we designed the largest one yet.

  • October 10, 2025

    Vyvgart brought us back to life, but the Long COVID trial was canceled. We are calling on the NIH and HHS to study the drug.

  • October 3, 2025

    Long COVID inspired me to start an IACC case competition at my business school. Here’s how you can get involved.

  • September 30, 2025

    Patricia Lockwood explores the depths of Long COVID in the new novel “Will There Ever Be Another You”

Previous Page
1 … 6 7 8 9 10 … 26
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...